Lactulosum Orifarm

Lactulose, the active ingredient in Lactulosum Orifarm, is an osmotic laxative presented as an oral formulation for oral use. It works by increasing the osmotic pressure in the intestinal lumen, drawing water into the bowel and reducing ammonia absorption. Clinically, it is used to relieve constipation and to manage hepatic encephalopathy in patients with liver disease.

GNH USA supplies Lactulosum Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product conforms to European Union quality standards and is manufactured under strict GMP conditions.

Lactulose is an osmotic laxative that acts on the gastrointestinal tract to treat conditions related to impaired bowel motility and ammonia accumulation.

- Constipation: softens stools and promotes bowel movements, helping to relieve chronic constipation. - Hepatic encephalopathy: lowers blood ammonia levels, improving neurological function in patients with liver‑derived encephalopathy. - Prevention of encephalopathy recurrence: maintains low ammonia concentrations to reduce the risk of recurrent episodes in cirrhotic patients.

Lactulose may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Abdominal cramping - Flatulence - Diarrhea - Nausea - Bloating

Serious or Rare Side Effects: - Severe dehydration - Electrolyte disturbances (e.g., hypokalemia) - Acute colitis - Allergic skin reactions (rash, urticaria) - Hypernatremia

When using Lactulose, several safety considerations should be observed. - Dose titration: start with the lowest effective dose and adjust based on clinical response. - Fluid intake: maintain adequate hydration to reduce the risk of dehydration. - Renal impairment: use with caution in patients with compromised kidney function. - Electrolyte monitoring: monitor serum electrolytes during prolonged therapy. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Lactulose can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antibiotics such as neomycin or rifaximin: may alter colonic flora and diminish lactulose effectiveness. - Antidiarrheal agents (e.g., loperamide): can counteract lactulose’s laxative action. - Mineral supplements (e.g., magnesium salts): additive osmotic effect may cause severe diarrhea.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes because combined osmotic effects can increase potassium loss. - Insulin or oral hypoglycemics: lactulose may affect carbohydrate absorption; blood glucose should be checked regularly.